Idiopathic Macular Telangiectasia Type 2. Diagnosis sustained in technical of images

Authors

Keywords:

idiopathic macular telangiectasia type 2, technical of images, diagnosis

Abstract

Introduction: Macular telangiectasia type 2 is an uncommon vascular disease characterized by telangiectasia and dilation of the retinal capillaries in the juxtafoveal area.
Patient report: We describe the clinical discoveries in multimodal images, fundus autofluorescence and optical coherence tomography, in a diagnosed patient with macular telangiectasia type 2.
Conclusions: These are useful and non-invasive imaging modality to identify the clinical features in macular telangiectasia type 2, even more sensitive than the fundus photograph. Can be used as a complementary imaging tool to fluorescein angiography, optical coherence tomography- angiography and fundus photograph.

Downloads

Download data is not yet available.

Author Biographies

Adonis Márquez Falcón, Arnaldo Milián Castro Clinical and Surgical University Hospital, Villa Clara, Cuba

First-level specialist in general medicine. Second-level specialist in ophthalmology. Assistant professor at the Villa Clara University of Medical Sciences.

Lidaisy Cabanes Goy, Arnaldo Milián Castro Clinical and Surgical University Hospital, Villa Clara, Cuba

First-degree specialist in general medicine. Second-degree specialist in ophthalmology. Assistant professor at the Villa Clara University of Medical Sciences.

Amanda Beatriz Luis González, Arnaldo Milián Castro Clinical and Surgical University Hospital, Villa Clara, Cuba

Resident physician in Ophthalmology

References

1. Chew EI, Spaide RF. Macular Telangiectasia Type 2. En: Ryan’s Retina. 7th ed. Países Bajos:Elsevier Editions; 2022.

2. Venkatesh R, Nahata H, Reddy NG, Mishra P, Mangla R, Yadav NK, et al. Is Type 2 Macular Telangiectasia a Bilateral and Symmetrical Disease Entity? J Curr Ophthalmol [Internet]. 2023 [citado 23/11/2024]; 34(4):[aprox. 2p.]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC10170975/

https://doi.org/10.4103/joco.joco_68_22

3. Starr MR, Iezzi R, Bakri SJ. Twenty-Year Incidence of Macular Telangiectasia Type 2 and Associated Systemic Comorbidities in Olmsted County, Minnesota. Ophthalmic Surg Lasers Imaging Retina [Internet]. 2020 [citado 23/11/2024]; 51(5): 35-42. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32484899/

https://doi.org/10.3928/23258160-20200108-05.

4. Kedarisetti KC, Narayanan R, Stewart MW, Reddy Gurram N, Khanani AM. Macular Telangiectasia Type 2: A Comprehensive Review. Clin Ophthalmol [Internet]. 2022 [citado 23/11/2024]; 16:[aprox.7p.]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9553319/

https://doi.org/10.2147/OPTH.S373538

5. van Romunde SHM, van der Sommen CM, Martinez Ciriano JP, Vingerling JR, Yzer S. Prevalence and Severity of Diabetic Retinopathy in Patients with Macular Telangiectasia Type 2. Ophthalmol Retina [Internet]. 2021 [citado 23/11/2024]; 5(10): [aprox. 4p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/33444807/

https://doi.org/10.1016/j.oret.2021.01.002

6. Chen YY, Chen YL, Wu JS, Chen SN. Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients. Taiwan J Ophthalmol [Internet]. 2023 [citado 23/11/2024]; 13(3): [aprox. 4p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/38089515/

https://doi.org/10.4103/tjo.tjo-d-22-00154

7. Totsuka K, Aoki S, Arai T, Kitamoto K, Azuma K, Fujino R, et al. Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients. Sci Rep [Internet]. 2023 [citado 23/11/2024]; 13(1): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37919473/

https://doi.org/10.1038/s41598-023-46394-4

8. Bottini AR, Blackorby BL, Michaels M, Burkett K, Dang S, Blinder KJ, et al. Long-Term Outcomes in Macular Telangiectasia Type 2 with Subretinal Neovascularization. J Vitreoretin Dis [Internet]. 2020 [citado 23/11/2024]; 4(5): [aprox. 3p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/37008296/

https://doi.org/10.1177/2474126420927149

9. Venkatesh R, Pereira A, Bavaharan B, Jain K, Aseem A, Sangai S, et al. Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia. J Curr Ophthalmol [Internet]. 2020 [citado 23/11/2024]; 32(4):âprox.3p.]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7861105/

https://doi.org/10.4103/JOCO.JOCO_96_20

10. Chandran K, Giridhar A, Desai S, Gopalakrishnan M, Indu VP, Sivaprasad S. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics. Indian J Ophthalmol [Internet]. 2024 [citado 23/11/2024]; 72(Suppl 1):S125-S134. Disponible en: https://pubmed.ncbi.nlm.nih.gov/38131554/

https://doi.org/10.4103/ijo.ijo_78_23

11. Pauleikhoff D, Pauleikhoff L, Chew EY. Imaging endpoints for clinical trials in MacTel type 2. Eye (Lond) [Internet]. 2022 [citado 23/11/2024]; 36(2):[aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34389818/

https://doi.org/10.1038/s41433-021-01723-7

12. Venkatesh R, Reddy NG, Mishra P, Agrawal S, Mutalik D, Yadav NK, et al. Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity. Int J Retina Vitreous [Internet]. 2022 [citado 23/11/2024]; 8(1): [aprox. 2p.].Disponible en: https://pubmed.ncbi.nlm.nih.gov/35382904/

https://doi.org/10.1186/s40942-022-00378-0

13. Cai CX, Choong J, Farsiu S, Chiu SJ, Chew EY, Jaffe GJ. Retinal cavitations in macular telangiectasia type 2 (MacTel): longitudinal structure-function correlations. Br J Ophthalmol [Internet]. 2021 [citado 23/11/2024]; 105(1): [aprox. 3p.]] Disponible en: https://pubmed.ncbi.nlm.nih.gov/32152145/

https://doi.org/10.1136/bjophthalmol-2019-315416

14. Goerdt L, Weinhold L, Isselmann B, Rodríguez García JL, Kunzel SH, Schmid M, et al. Relative ellipsoidzone reflectivity in macular telangiectasia type 2. Invest Ophthalmol Vis Sci [Internet]. 2023 [citado 23/11/2024]; 64(10): [aprox. 2p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/37462978/

https://doi.org/10.1167/iovs.64.10.21

15. Chandran K, Giridhar A, Gopalakrishnan M, Sivaprasad S. Microvascular changes precede visible neurodegeneration in fellow eyes of patients with asymmetric type 2 macular telangiectasia. Eye (Lond) [Internet]. 2022 [citado 23/11/2024]; 36(8): [aprox. 3p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34326496/

https://doi.org/10.1038/s41433-021-01699-4

Downloads

Published

2025-05-15

How to Cite

1.
Márquez Falcón A, Cabanes Goy L, Luis González AB. Idiopathic Macular Telangiectasia Type 2. Diagnosis sustained in technical of images. Acta Méd Centro [Internet]. 2025 May 15 [cited 2025 Jul. 1];19(1):e2044. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/e2044

Issue

Vol. 19 (2025): PUBLICACIÓN CONTINUA

Section

Case Reports

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).